© 1994 by Oxford University Press
Infant Leukemia, Topoisomerase II Inhibitors, and the MLL Gene
Julie A. Ross, John D. Potter, and Leslie L. Robison
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Virology..Leukemia Virus
- Medicine..Treatment Options for Leukemia
- Oncology..Leukemia (Childhood)
- Oncology..Leukemia
- Oncology..Childhood Cancers
- Oncology..Treatment Options for Lung Cancer
- Oncology..Detection/Screening and Prognosis of Leukemia
- Oncology..Treatment Options for Germ Cell Cancer
- Oncology..Treatment Options for Testicular Cancer
- Oncology..Hodgkin's Lymphoma (Childhood)
- Oncology..Etoposide
- Oncology..Diagnosis
- Oncology..Radiation Therapy
- Biophysics..Topoisomerases
- Genetics..Homeobox Genes
- Oncology..Germ Cell Tumors (Childhood)
- Oncology..Acute Lymphocytic Leukemia (Childhood)
- Oncology..Acute Myeloid Leukemia (Childhood)
- Oncology..Lymphoma (Childhood)
- Genetics..Chromosomal Bands
This article has been cited by other articles:
![]() |
C. Bueno, P. Catalina, G. J. Melen, R. Montes, L. Sanchez, G. Ligero, J. L. Garcia-Perez, and P. Menendez Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells Carcinogenesis, September 1, 2009; 30(9): 1628 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Deweese and N. Osheroff The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing Nucleic Acids Res., February 1, 2009; 37(3): 738 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Guha, J. S. Chang, A. P. Chokkalingam, J. L. Wiemels, M. T. Smith, and P. A. Buffler NQO1 Polymorphisms and De Novo Childhood Leukemia: A HuGE Review and Meta-Analysis Am. J. Epidemiol., December 1, 2008; 168(11): 1221 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ross Environmental and Genetic Susceptibility to MLL-Defined Infant Leukemia J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 83 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten Dietary flavonoids induce MLL translocations in primary human CD34+ cells Carcinogenesis, August 1, 2007; 28(8): 1703 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Pombo-de-Oliveira, S. Koifman, and Brazilian Collaborative Study Group of Infant Acut Infant Acute Leukemia and Maternal Exposures during Pregnancy Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2336 - 2341. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Johnson, L. Dooley, R. L. Morrissey, L. Arp, I. Kapetanovic, J. A. Crowell, and D. L. McCormick Oncogenicity Evaluations of Chemopreventive Soy Components in p53(+/-) (p53 knockout) Mice International Journal of Toxicology, May 1, 2006; 25(3): 219 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Spector, Y. Xie, L. L. Robison, N. A. Heerema, J. M. Hilden, B. Lange, C. A. Felix, S. M. Davies, J. Slavin, J. D. Potter, et al. Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 651 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Greaves, A. T. Maia, J. L. Wiemels, and A. M. Ford Leukemia in twins: lessons in natural history Blood, October 1, 2003; 102(7): 2321 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oguchi, M. Takagi, R. Tsuchida, Y. Taya, E. Ito, K. Isoyama, E. Ishii, L. Zannini, D. Delia, and S. Mizutani Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement Blood, May 1, 2003; 101(9): 3622 - 3627. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Miltyk, C. N Craciunescu, L. Fischer, R. A Jeffcoat, M. A Koch, W. Lopaczynski, C. Mahoney, R. A Jeffcoat, J. Crowell, J. Paglieri, et al. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer Am. J. Clinical Nutrition, April 1, 2003; 77(4): 875 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Robien and C. M. Ulrich 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Leukemia Risk: A HuGE Minireview Am. J. Epidemiol., April 1, 2003; 157(7): 571 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Alexander, S. L. Patheal, A. Biondi, S. Brandalise, M.-E. Cabrera, L. C. Chan, Z. Chen, G. Cimino, J.-C. Cordoba, L.-J. Gu, et al. Transplacental Chemical Exposure and Risk of Infant Leukemia with MLL Gene Fusion Cancer Res., March 1, 2001; 61(6): 2542 - 2546. [Abstract] [Full Text] |
||||
![]() |
J.M. Gee, H.P.J.M. Noteborn, A.C.J. Polley, and I.T. Johnson Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein Carcinogenesis, December 1, 2000; 21(12): 2255 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ross Dietary flavonoids and the MLL gene: A pathway to infant leukemia? PNAS, April 25, 2000; 97(9): 4411 - 4413. [Full Text] [PDF] |
||||
![]() |
J. L. Wiemels, A. Pagnamenta, G. M. Taylor, O. B. Eden, F. E. Alexander, and M. F. Greaves A Lack of a Functional NAD(P)H:Quinone Oxidoreductase Allele Is Selectively Associated with Pediatric Leukemias That Have MLL Fusions Cancer Res., August 1, 1999; 59(16): 4095 - 4099. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Gale, A. M. Ford, R. Repp, A. Borkhardt, C. Keller, O. B. Eden, and M. F. Greaves Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots PNAS, December 9, 1997; 94(25): 13950 - 13954. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Chen, Q. Liu, C.-H. Pui, G. K. Rivera, J. T. Sandlund, R. Ribeiro, W. E. Evans, and M. V. Relling Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic Leukemia Blood, March 1, 1997; 89(5): 1701 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Kingma and N. Osheroff Apurinic Sites Are Position-specific Topoisomerase II Poisons J. Biol. Chem., January 10, 1997; 272(2): 1148 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L Robison Second primary cancers after childhood cancer BMJ, April 6, 1996; 312(7035): 861 - 862. [Full Text] |
||||
![]() |
P. S. Kingma, A. H. Corbett, P. C. Burcham, L. J. Marnett, and N. Osheroff Abasic Sites Stimulate Double-stranded DNA Cleavage Mediated by Topoisomerase II J. Biol. Chem., September 15, 1995; 270(37): 21441 - 21444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wiemels, R. N. Smith, G. M. Taylor, O. B. Eden, F. E. Alexander, M. F. Greaves, and United Kingdom Childhood Cancer Study Investigator Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia PNAS, March 27, 2001; 98(7): 4004 - 4009. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Strick, P. L. Strissel, S. Borgers, S. L. Smith, and J. D. Rowley From the Cover: Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia PNAS, April 25, 2000; 97(9): 4790 - 4795. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||











